CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cytopia Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cytopia Limited
Level 5
Baker Heart Institue Building
Phone: (3) 952-26900p:3 952-26900 Melbourne, VIC  3004  Australia Ticker: CYT CYT

This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Cytopia Limited (Cytopia) is an Australia-based company. The Company is engaged in the business of drug discovery research and development through its subsidiaries Cytopia Research Pty Ltd (Cytopia Research) and Cytopia Inc focusing on cancer and inflammatory diseases. The Company is developing CYT997, an anticancer agent that disrupts tumour blood vessels. CYT997 is being investigated in Phase II clinical trials in a variety of cancers. The Company is also undertaking two Phase II efficacy studies. Cytopia opened its trial for CYT997 in relapsed glioma, a form of brain tumour, in September 2008. The Company is also undertaking a Phase II study in multiple myeloma, a disorder of the bone marrow. In February 2010, the Company merged into YM BioSciences Inc.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20096/30/2009Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non - Executive Chairman of the Board RobertWatson 53 11/23/2006 6/16/2003
Chief Executive Officer, Managing Director, Executive Director AndrewMacdonald 49 10/29/2007 8/1/2005
Vice Chairman, Non-Executive Director GeoffreyVaughan 76 5/8/1998
3 additional Officers and Directors records available in full report.

Business Names
Business Name
CYT
Cytopia Limited
Medica Holdings Limited

General Information
Number of Employees: 28 (As of 6/30/2005)
Outstanding Shares: 84,691,304 (As of 6/30/2009)
Shareholders: 736
Stock Exchange: ASX
Fax Number: (3) 951-09292


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023